Insud’s Xiromed Rivals Taytulla In US
Follows First-To Market Launch Of Monurol With CGT Designation
Xiromed has announced the introduction of the first generic rival to the Taytulla contraceptive in the US. The launch of Gemmily represents the latest new product for the Insud subsidiary following a busy year.
